Search

Author/Creator Plesner, Torben

2. A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. (4th December 2012)

Authors:
Popat, Rakesh; Plesner, Torben; Davies, Faith; Cook, Gordon; Cook, Mark; Elliott, Peter; Jacobson, Eric; Gumbleton, Todd; Oakervee, Heather; Cavenagh, Jamie
Journal:
British journal of haematology
Issue:
Volume 160:Number 5(2013:Mar.)
Page Start:
714
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. (24th August 2013)

Authors:
Birgens, Henrik; Frederiksen, Henrik; Hasselbalch, Hans C.; Rasmussen, Inge H.; Nielsen, Ove J.; Kjeldsen, Lars; Larsen, Herdis; Mourits‐Andersen, Torben; Plesner, Torben; Rønnov‐Jessen, Dorthe; Vestergaard, Hanne; Klausen, Tobias W.; Schöllkopf, Claudia
Journal:
British journal of haematology
Issue:
Volume 163:Number 3(2013:Nov.)
Page Start:
393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinically‐suspected cast nephropathy: A retrospective, national, real‐world study. Issue 11 (26th August 2020)

Authors:
Szabo, Agoston G.; Thorsen, Jonathan; Iversen, Katrine F.; Hansen, Charlotte T.; Teodorescu, Elena M.; Pedersen, Simon B.; Flæng, Simon B.; Strandholdt, Casper; Frederiksen, Mikael; Vase, Maja Ø.; Frølund, Ulf C.; Krustrup, Dorrit; Plesner, Torben; Vangsted, Annette J.
Journal:
American journal of hematology
Issue:
Volume 95:Issue 11(2020:Nov.)
Page Start:
1352
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Issue 2 (28th January 2023)

Authors:
Nahi, Hareth; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Oriol, Albert; Plesner, Torben; Bandyopadhyay, Nibedita; Hellemans, Peter; Tromp, Brenda; Nnane, Ivo; Zemlickis, Donna; Chari, Ajai; Moreau, Philippe
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 2(2023)
Page Start:
468
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials. Issue 6 (June 2020)

Authors:
Usmani, Saad Z; Nahi, Hareth; Plesner, Torben; Weiss, Brendan M; Bahlis, Nizar J; Belch, Andrew; Voorhees, Peter M; Laubach, Jacob P; van de Donk, Niels W C J; Ahmadi, Tahamtan; Uhlar, Clarissa M; Wang, Jianping; Feng, Huaibao; Qi, Ming; Richardson, Paul G; Lonial, Sagar
Journal:
Lancet
Issue:
Volume 7:Issue 6(2020)
Page Start:
e447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial. Issue 11 (November 2021)

Authors:
Facon, Thierry; Kumar, Shaji K; Plesner, Torben; Orlowski, Robert Z; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; O'Dwyer, Michael; Perrot, Aurore; Venner, Christopher P; Weisel, Katja; Mace, Joseph R; Raje, Noopur; Tiab, Mourad...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 11(2021)
Page Start:
1582
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Effects of single‐agent bortezomib as post‐transplant consolidation therapy on multiple myeloma‐related bone disease: a randomized phase II study. (6th April 2017)

Authors:
Sezer, Orhan; Beksac, Meral; Hajek, Roman; Sucak, Gülsan; Cagirgan, Seckin; Linkesch, Werner; Meltem Akay, Olga; Gülbas, Zafer; Nahi, Hareth; Plesner, Torben; Snowden, John A.; Timurağaoğlu, Ayşen; Dechow, Tobias; Lang, Alois; Tuğlular, Tülin; Drach, Johannes; Armbrecht, Gabriele; Potamianou, Ann...
Journal:
British journal of haematology
Issue:
Volume 178:Number 1(2017)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open‐label, phase 1/2 study. (31st March 2019)

Authors:
Plesner, Torben; Arkenau, Hendrik‐Tobias; Gay, Francesca; Minnema, Monique C.; Boccadoro, Mario; Moreau, Philippe; Cavenagh, Jamie; Perrot, Aurore; Laubach, Jacob P.; Krejcik, Jakub; Ahmadi, Tahamtan; de Boer, Carla; Chen, Diana; Chiu, Christopher; Schecter, Jordan M.; Richardson, Paul G.
Journal:
British journal of haematology
Issue:
Volume 186:Number 3(2019)
Page Start:
e35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗